Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.
about
Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioningGenetic barriers in transplantation medicineGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveImproving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantationImmune-based therapeutics for pediatric cancer.Hematopoietic stem cell transplantation for MDS.T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCTThe outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age.Hematopoietic stem cell transplantation in China: current status and prospectsComparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide.Reconstitution and clinical significance of T cell subsets in the early stage after related HLA-mismatched peripheral blood hematopoietic SCT without T-cell depletion in vitro.Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO eraImmunotherapy following hematopoietic stem cell transplantation: potential for synergistic effectsAllogeneic hematopoietic cell transplantation for MDS: for whom, when and how?Cellular therapies in acute lymphoblastic leukemiaTimeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation.Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute LeukemiaFrequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: current status.Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?T cell depletion in paediatric stem cell transplantation.The current role of T cell depletion in paediatric stem cell transplantation.Experts' considerations on HLA-haploidentical stem cell transplantation.G-CSF-primed BM for allogeneic SCT: revisited.Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia.Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing's sarcoma patients.Longer delay of hematological recovery and increased transfusion needs after haploidentical compared to non-haploidentical stem cell transplantation.Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.Cellular therapies in acute lymphoblastic leukemia.The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT.Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD.Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors.Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.
P2860
Q26795740-FF19CA97-5137-47A4-9399-1BBE4C73A377Q28069956-4B015769-C8A1-45E2-AE1A-98EC7873A086Q28388806-81FC28E3-8213-4ED3-AB81-ADF440F8DC4EQ33597783-65E62F00-623C-4F8F-BEEC-C0FE350AF827Q33604121-80445735-D634-487E-BE08-B9F22731CF5CQ33767314-748FA0BD-F71B-4FCE-BF86-85CA0DB33AFEQ34398411-2F4FD397-8AC4-4813-9FC6-56982EE3EC92Q35041195-2228DF22-96AF-427B-BB27-4E5E51A6B17EQ35824935-06C2FAA0-0C91-4E7A-8D80-24567140EA07Q36028504-E9017429-8561-4704-B682-6A8B2028E0C3Q36095082-45FC52A6-9E58-43AC-B818-EDDED6C81EE4Q36366631-0649034C-3002-4849-9287-EAC9EB843714Q36380188-4E3E53BD-16B8-4631-BFDC-5D3D7CFC501FQ36431041-90B8A811-D89E-42F2-AE42-D80B8E551F17Q36552098-620FE682-92FB-48A8-BF62-C01D7B81E8BCQ36560134-68E92F9E-D4D7-4F21-964E-DA9AD8200033Q36822659-638DAAB3-419B-4E3E-8679-889C5E8049D5Q37249351-A9BBC5C2-FDD1-4062-9306-D0EBD3879119Q37964938-AC9C3587-CF39-476C-B163-C5ACD2ED0031Q38087853-56267BA7-D166-41C8-9D10-5E8BF2D2BF2CQ38097916-08CC9B82-96D5-40BF-9CA0-873369379F05Q38110308-C1BE5603-CC0D-4175-81D5-A993DBAF582BQ38198728-05BA2478-F1D4-46CA-8519-F56DC352A420Q38366631-7DA0B957-F961-4A98-9BA0-E93DA6B90578Q38616426-40F48845-F610-4F0A-8760-C7D64D47A9E7Q38868011-5D7108E6-DBF7-431B-A3B2-AA0736A1003CQ40819256-DA828090-A2B1-4ACA-9E47-097EE38F3957Q41092916-CD37E881-CA6D-4C08-BF47-C097AA5A2BACQ41560177-D3B1A31D-974A-426D-A445-DB9D1C1AA5BFQ42247726-D47D4DF5-A05B-4ABE-9646-D3F19CAE33FFQ43811410-28F8BD46-C364-4522-B468-0D52EA72D928Q47568213-956D1C78-35D8-44D2-9212-50237C5AAD09Q47983957-34EC1319-2577-4017-8F32-5B5F36FFBB57Q50588099-8DFECD59-A26A-486D-91B4-76F5F7F117B0Q54546815-FC87ED4C-221D-42B5-BD28-0B0895E6FCBC
P2860
Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Haploidentical haematopoietic ...... Europe and the United States.
@en
Haploidentical haematopoietic ...... Europe and the United States.
@nl
type
label
Haploidentical haematopoietic ...... Europe and the United States.
@en
Haploidentical haematopoietic ...... Europe and the United States.
@nl
prefLabel
Haploidentical haematopoietic ...... Europe and the United States.
@en
Haploidentical haematopoietic ...... Europe and the United States.
@nl
P2860
P356
P1476
Haploidentical haematopoietic ...... n Europe and the United States
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705966
P407
P577
2008-01-07T00:00:00Z